
Taking a child into a clinic for a strep throat test can be a costly and time-intensive burden for many parents. But a Brookline-based entrepreneur said she has a solution: an at-home strep test.
Nathalya Mamane launched her company, RT MicroDx, in June 2021. She’s developing what the company describes as the first over-the-counter, molecular-based test for streptococcal pharyngitis, and she says she eventually hopes to expand into tests for other pathogens.
While Mamane’s idea sounds straightforward, her path to launching RT MicroDx was anything but.
An unusual path
Mamane is not a scientist. She worked in event planning for 20 years, 15 at her own company, before realizing it wasn’t fulfilling her anymore. Still, she said, no one could see her doing anything else but hospitality, so at 45 years old, Mamane went back to school to get an MBA from Babson College. Even as she started her classes, she still wasn’t sure what she was going to do.
“I went through school, I really didn’t know where that was going to take me. But I said, ‘I’m just going to let school guide me and inspire me,’” Mamane said.
As part of a group project in her final year, she was tasked with developing a product to pitch to healthcare giant Johnson & Johnson. That’s when she thought of creating an at-home test for strep throat. As a mother of four, she said, she knew how useful that faster option would be.
A pandemic-era product
At the time she came up with the idea, many people were becoming accustomed to rapid at-home tests because of the Covid-19 pandemic. The pandemic also meant that Mamane’s daughter Olivia was doing college classes from home. Olivia Mamane, who was then a senior studying bioengineering at McGill University, overheard her mother talking about the idea and wanted to get involved. So for her capstone senior project at McGill, she developed the first version of the at-home test.
With the technology developed by her daughter in her pocket, Mamane was accepted into Babson’s accelerator program, which helps launch startups.
“I literally thought I won the lottery. This was my first ‘yes.’ We were so excited,” Mamane said. “And it really propelled me to where I am today.”
Babson’s accelerator program connected her with a technical team and with an advisory board, which has helped push the company forward, Mamane said.
Next steps
RT MicroDx has seen a string of successes, like winning the 2022 Babson Entrepreneurial Thoughts & Action Challenge, being named a runner-up in the MIT $100K Entrepreneurship Competition and becoming a finalist in MassChallenge’s Resolve 2023 awards.
But it still has work to do before its tests appear on shelves.
RT MicroDx is now working from a lab in Newton to perfect Olivia Mamane’s prototype and create an inexpensive, highly effective test. Mamane is confident the company will move into the next product-development phase in the coming months.
The company’s prototype is based on lateral-flow assay technology — test strips that react to the presence of biomarkers in bodily fluids — similar to Covid-19 or pregnancy tests. But RT MicroDx’s strep test strip would react to the presence of certain DNA. Mamane said her hope is that by using DNA, her tests could eventually detect a broad range of common diseases.
“We’re making it simple. We’re making it saliva-based, so it’s not invasive,” she said. “The idea is, we make it cheap so that people can just buy it.”
Currently, there are seven members of the team, including Olivia, who is now 25. But in order to bring it to the next level, Mamane said she needs more funding.
“Now I’m looking to raise money, because the next phase is where things are going to get really expensive,” she said. “We’re just right now putting energies into optimization now, so that when we move into product development, it will be faster.”